Journal of Traditional Chinese Medicine >
Qufeng Jiejing formula (祛风解痉方) ameliorated the injury of airway smooth muscle cells induced by platelet-derived growth factor-BB through the transforming growth factor-β1/Smads signaling pathway
Received date: 2024-07-23
Accepted date: 2024-12-31
Online published: 2025-07-25
Supported by
Science and Technology Innovation Project of China Academy of Chinese Medical Sciences of Study on the Mechanism of Qufeng Jiejing Formula in Regulating Mitogen-activated Protein Kinase Signaling Pathway to Inhibit Phenotypic Transformation of Airway Smooth Muscle Cells in Asthma(CI2021A01108);Cultivation Project of The National Natural Science Foundation of China of Xiyuan Hospital, China Academy of Chinese Medical Sciences of Research on the Role of Traditional Chinese Medicines-Qufeng Jiejing in the Proliferation, Migration and Phenotypic Transformation of Airway Smooth Muscle Cells in Asthma(XY20-17)
OBJECTIVE: To explore the role and mechanism of Qufeng Jiejing (祛风解痉,QFJJ) formula in the asthma progression.
METHODS: The Bagg Albino/c mice treated with Ovalbumin and AL(OH)3, and airway smooth muscle cells (ASMCs) treated with platelet-derived growth factor (PDGF)-BB to establish a asthma model in vivo and in vitro. The cell morphology was observed with microscope and immunofluorescence staining. The cell viability was assessed with methyl thiazolyl tetrazolium assay. The tumor necrosis factor-αlpha (TNF-α), interleukin-1beta (IL-1β), laminin, fibronectin and collagen IV levels in the ASMCs were detected with corresponding enzyme linked immunosorbent assay kits. Transwell and wound healing assays were conducted to test the cell migration. The TGF-β1, Smad2 and Smad3 levels were measured with Western blot.
RESULTS: We found that QFJJ formula treatment dramatically decreased the cell viability, TNF-α, IL-1β, laminin, fibronectin and collagen IV levels in the PDGF-BB stimulated ASMCs. Additionally, the protein levels of TGF-β1, Smad2 and Smad3 in the PDGF-BB stimulated ASMCs were prominently depleted after QFJJ formula treatment. Besides, SRI treatment neutralized the role of QFJJ formula in the PDGF-BB stimulated ASMCs.
CONCLUSION: QFJJ formula effectively relieved the asthma progression through ameliorate the ASMCs function, which was achieved through suppressing the TGF-β1/Smads signaling pathway.
Changzheng FAN , Qiong ZHANG , Maorong FAN , Hongxu MENG , Xiaodong CONG , Yiling FAN , Shasha YUAN , Qing MIAO . Qufeng Jiejing formula (祛风解痉方) ameliorated the injury of airway smooth muscle cells induced by platelet-derived growth factor-BB through the transforming growth factor-β1/Smads signaling pathway[J]. Journal of Traditional Chinese Medicine, 2025 , 45(4) : 730 -738 . DOI: 10.19852/j.cnki.jtcm.2025.04.003
| 1. | Alwarith J, Kahleova H, Crosby L, et al. The role of nutrition in asthma prevention and treatment. Nutr Rev 2020; 78: 928-38. |
| 2. | Kaur R, Chupp G. Phenotypes and endotypes of adult asthma: Moving toward precision medicine. J Allergy Clin Immunol 2019; 144: 1-12. |
| 3. | Huang Z, Gao L, Zhao X, et al. Effect of Gubenfangxiao decoction on respiratory syncytial virus-induced asthma and expression of asthma susceptibility gene orosomucoid 1-like protein 3 in mice. J Tradit Chin Med 2016; 36: 101-6. |
| 4. | Bates JHT. Physiological mechanisms of airway hyper-responsiveness in obese asthma. Am J Respir Cell Mol Biol 2016; 54: 618-23. |
| 5. | Ding LZ, Zhang Q, Sun YY, et al. Untargeted serum metabonomic reveals alleviated ovalbumin-induced asthma by Baijin Pingchuan through primary bile acid biosynthesis. J Tradit Chin Med 2024; 44: 1187-93. |
| 6. | Sobieraj DM, Weeda ER, Nguyen E, et al. Association of inhaled corticosteroids and long-Acting beta-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: a systematic review and Meta-analysis. JAMA 2018; 319: 1485-96. |
| 7. | Ora J, Calzetta L, Matera MG, Cazzola M, Rogliani P. Advances with glucocorticoids in the treatment of asthma: state of the art. Expert Opin Pharmacother 2020; 21: 2305-16. |
| 8. | Abramson MJ, Walters J, Walters EH. Adverse effects of beta-agonists: are they clinically relevant? Am J Respir Med 2003; 2: 287-97. |
| 9. | Camoretti-Mercado B, Lockey RF. Airway smooth muscle pathophysiology in asthma. J Allergy Clin Immunol 2021; 147: 1983-95. |
| 10. | Kume H. Role of airway smooth muscle in inflammation related to asthma and COPD. Adv Exp Med Biol 2021; 1303: 139-72. |
| 11. | James AL, Noble PB, Drew S, et al. Airway smooth muscle proliferation and inflammation in asthma. J Appl Physiol (1985) 2018; 125: 1090-6. |
| 12. | Salter B, Pray C, Radford K, Martin JG, Nair P. Regulation of human airway smooth muscle cell migration and relevance to asthma. Respir Res 2017; 18: 156. |
| 13. | Chen A. Traditional Chinese Medicine in treatment of bronchitis and bronchial asthma. J Tradit Chin Med 1998; 18: 71-6. |
| 14. | Li J, Zhang F, Li J. The immunoregulatory effects of Traditional Chinese Medicine on treatment of asthma or asthmatic inflammation. Am J Chin Med (1979) 2015; 43: 1059. |
| 15. | Wang J, Sun R, Wang R, et al. A traditional Chinese patent medicine-Suhuang zhike capsule for cough variant asthma in adults: a protocol of systematic review and Meta-analysis of randomized controlled trials. Medicine (Baltimore) 2019; 98: e18335. |
| 16. | Chen X, Zhang X, Jianning LI. Effect of Qufeng Jiejing decoction combined with acupoint application on airway responsiveness for adult cough variant asthma. Sichuan Zhong Yi Za Zhi 2018; 36: 99-101. |
| 17. | Changzheng F, Yuzhen P, Xiaodong C, et al. Effects of qufeng jiejing decoction on airway hyperresponsiveness in patients with bronchial asthma. J Tradit Chin Med 2018; 59: 2107-10. |
| 18. | Song P, Zhang X, Zhang T, Zhang Z. Pharmacological activity of Qufeng Jiejing decoction in treating cough variant asthma. Zhong Guo Yi Yao Dao Bao 2018; 15: 14-7. |
| 19. | Yao Z, Fu Y. Glycyrrhizic acid restrains airway inflammation and remodeling in asthma via the TGF-beta1/Smad signaling pathway. Exp Ther Med 2021; 21: 461. |
| 20. | Dai R, Wang Y, Wang N. Betalain alleviates airway inflammation in an ovalbumin-induced-asthma mouse model via the TGF-β1/ Smad signaling pathway. J Environ Pathol Tox 2021; 40: 11. |
| 21. | Brown SDPM, Baxter KMB, Stephenson STP, Esper AMM, Brown LASP, Fitzpatrick AMPM. Airway TGF-β1 and oxidant stress in children with severe asthma: association with airflow limitation. J Allergy Clin Immunol 2012; 129: 388-96. |
| 22. | Lan HYMP, Chung ACKP. TGF-β/Smad signaling in kidney disease. Semin Nephrol 2012; 32: 236-43. |
| 23. | Song Y, Wang Z, Jiang J, et al. DEK-targeting aptamer DTA-64 attenuates bronchial EMT-mediated airway remodelling by suppressing TGF-beta1/Smad, MAPK and PI3K signalling pathway in asthma. J Cell Mol Med 2020; 24: 13739-50. |
| 24. | Zheng Y, Li L, Cai T. Cordyceps polysaccharide ameliorates airway inflammation in an ovalbumin-induced mouse model of asthma via TGF-β1/Smad signaling pathway. Respir Physiol Neurobiol 2020; 276: 103412. |
| 25. | Wang Z, Wang Z, Geliebter J, Tiwari R, Li X. Traditional Chinese Medicine for food allergy and eczema. Ann Allerg Asthma Im 2021; 126: 639-54. |
| 26. | Zhang HP, Wang L, Wang Z, et al. Chinese herbal medicine formula for acute asthma: a multi-center, randomized, double-blind, proof-of-concept trial. Respir Med 2018; 140: 42-9. |
| 27. | Yu M, Jia H, Cui F, et al. The effect of chinese herbal medicine formula mKG on allergic asthma by regulating lung and plasma metabolic alternations. Int J Mol Sci 2017; 18: 602. |
| 28. | Ruan G, Tao B, Wang D, Li Y, Wu J, Yin G. Chinese herbal medicine formula GuBenFangXiaoTang attenuates airway infla-mmation by modulating Th17/Treg balance in an oval-bumininduced murine asthma model. Exp Ther Med 2016; 12: 1428-34. |
| 29. | Wang Z, Li R, Zhong R. Extracellular matrix promotes proliferation, migration and adhesion of airway smooth muscle cells in a rat model of chronic obstructive pulmonary disease via upregulation of the PI3K/AKT signaling pathway. Mol Med Rep 2018; 18: 3143-52. |
| 30. | Zhou R, Chen X. Dexmedetomidine represses TGF-β1-induced extracellular matrix production and proliferation of airway smooth muscle cells by inhibiting MAPK signaling pathway. Allergol Immunopathol (Madr) 2022; 50: 16-22. |
| 31. | Theocharis AD, Manou D, Karamanos NK. The extracellular matrix as a multitasking player in disease. Febs J 2019; 286: 2830-69. |
| 32. | Zhang H, Yan HL, Li XY, Guo YN. TNFSF14, a novel target of miR-326, facilitates airway remodeling in airway smooth muscle cells via inducing extracellular matrix protein deposition and proliferation. Kaohsiung J Med Sci 2020; 36: 508-14. |
| 33. | Howell JE, McAnulty RJ. TGF-beta: its role in asthma and therapeutic potential. Curr Drug Targets 2006; 7: 547-65. |
| 34. | Paw M, Wnuk D, Kadziolka D, et al. Fenofibrate reduces the asthma-related fibroblast-to-myofibroblast transition by TGF-Beta/Smad2/3 signaling attenuation and connexin 43-dependent phenotype destabilization. Int J Mol Sci 2018; 19: 1-16. |
| 35. | Dong L, Wang Y, Zheng T, et al. Hypoxic hUCMSC-derived extracellular vesicles attenuate allergic airway inflammation and airway remodeling in chronic asthma mice. Stem Cell Res Ther 2021; 12: 4. |
| 36. | Yeh HW, Hsu EC, Lee SS, et al. PSPC1 mediates TGF-beta1 autocrine signalling and Smad2/3 target switching to promote EMT, stemness and metastasis. Nat Cell Biol 2018; 20: 479-91. |
/
| 〈 |
|
〉 |